We are pleased to announce the availability of the above-mentioned report, which came out in July 2013. Published regularly since 1984, this new report has been updated with data collected in some seventy countries over the last three years. It provides sales data in units, dollars, and market shares by company and by region for each of the therapeutic plasma and recombinant proteins listed below. Pricing trends over the last ten years, and projections to 2012 are also provided.
• Polyvalent Intravenous Immune Globulin (IVIG)
• Polyvalent Intramuscular/Subcutaneous Immune Globulin
• Hyperimmune Globulins (Tetanus, Rho(D), Hepatitis B, Rabies, etc.
• Factor VIII and Factor IX (plasma-derived and recombinant)
• von Willebrand Factor,
• Prothrombin Complex
• Activated Prothrombin Complex and recombinant Factor VIIa
• Additional Factor Proteins (Factor X, XIII, etc.
• Antithrombin III
• Alpha-1 Antitrypsin
• Fibrin Adhesive, and
This study analyzes recent industry developments that have led the global plasma protein market to grow from about $11.3 billion to $13.3 billion between 2008 and 2010 and even higher in 2012. Its table of contents is enclosed.
THE WORLDWIDE PLASMA PROTEINS MARKET 2012
TABLE OF CONTENTS
|Worldwide market by Region||18|
|Worldwide market by Product||22|
|Worldwide market by Company||
|Polyvalent Intramuscular/Subcutaneous Immune Globulin (IMIG)||40|
|Polyvalent Intravenous Immune Globulin (IVIG)||46|
|Tetanus Immune Globulin||54|
|Rho(D) Immune Globulin||60|
|Hepatitis B Immune Globulin (IM/IV)||66|
|Rabies Hyperimmune Globulin||73|
|Cytomegalovirus Hyperimmune Globulin (CMV)||79|
|Allergy Hyperimmune Globulin||81|
|All Other Hyperimmune Globulin||84|
|Albumin and Plasma Protein Fraction (PPF)||85|
|Prothrombin Complex (PCC/PPSB)||115|
|Activated Prothrombin Complex & Recombinant Factor VIIa||117|
|von Willebrand Factor||119|
|All Other Products||140|